Funding

Moleculent

Sweden · Biotech · Healthtech

Decodes cellular networks to advance human health

Visit moleculent.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Undisclosed$20MARCH Venture Partners — Role not disclosedEir Ventures — Role not disclosedRubicon Healthcare Partners — Role not disclosed

Investors

ARCH Venture PartnersUndisclosedEir VenturesUndisclosedRubicon Healthcare PartnersUndisclosed

Coverage

Apr 30, 2026Moleculent · Undisclosed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesmoleculent.com ↗